Home › NDC Lookup › RxCUI directory › RxCUI 1234512

Hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion — RxCUI 1234512

RxNorm drug concept · Semantic clinical drug
RxCUI 1234512 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1234512
Official nameHydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydrocortisone acetate 2.5 % / pramoxine hydrochloride 1 % Rectal Lotion; hydrocortisone acetate 2.5 % / pramoxine HCl 1 % Rectal Lotion
FDA products mapped4
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This is a corticosteroid enema used specifically for ulcerative colitis that affects the lower part of your colon — the rectum and the left side. Rather than treating the whole bod...
  • What exactly is this enema treating — is it the same as regular colitis medicine?
  • Many people notice symptoms like diarrhea and bleeding improving within 3 to 5 days. That said, the actual healing of the colon lining often takes longer to show up — sometimes wee...
  • How long do I need to use it before it starts working?
📖 Read our full Hydrocortisone Rectal guide →

🕸️ Concept Web — How Hydrocortisone acetate 25 MG/ML / pramoxine hydr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion RxCUI 1234512

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Hydrocortisone 5492
    • Pramoxine 34347
    • Hydrocortisone / pramoxine 106955
    • Hydrocortisone acetate 27197
    • Pramoxine hydrochloride 57555
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Analpram HC 215264
    • Pramosone 219334
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydrocortisone / pramoxine Topical Lotion 377722
    • Hydrocortisone acetate / pramoxine hydrochloride Topical Lotion 2647793
    • Hydrocortisone / pramoxine Topical Product 1164001
    • Hydrocortisone acetate / pramoxine hydrochloride Topical Product 2662709
    • Hydrocortisone / pramoxine Topical Lotion [Analpram HC] 365803
    • Hydrocortisone / pramoxine Topical Lotion [Pramosone] 1234395
    • Hydrocortisone acetate / pramoxine hydrochloride Topical Lotion [Analpram HC] 2655982
    • Hydrocortisone acetate / pramoxine hydrochloride Topical Lotion [Pramosone] 2658672
    • +4 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 21 of 25 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydrocortisone acetate 25 MG/ML SCDC · 1234505
  • Pramoxine hydrochloride 10 MG/ML SCDC · 828361
  • Hydrocortisone / pramoxine Topical Lotion SCDF · 377722
  • Hydrocortisone acetate / pramoxine hydrochloride Topical Lotion SCDFP · 2647793
  • Hydrocortisone / pramoxine Topical Product SCDG · 1164001
  • Hydrocortisone acetate / pramoxine hydrochloride Topical Product SCDGP · 2662709

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 6 package NDCs
6 package NDCs map to RxCUI 1234512 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
54766-0726-04 118 mL in 1 BOTTLE, PLASTIC (54766-726-04) Pramosone Sebela Pharmaceuticals Inc. 2015-08-07
54766-0726-06 59 mL in 1 BOTTLE, PLASTIC (54766-726-06) Pramosone Sebela Pharmaceuticals Inc. 2015-08-07
54766-0829-04 59 mL in 1 BOTTLE, PLASTIC (54766-829-04) Analpram HC Sebela Pharmaceuticals Inc. 2015-08-05
83107-0020-02 59 mL in 1 BOTTLE, PLASTIC (83107-020-02) Analpram HC Legacy Pharma USA Inc. 2025-05-23
83107-0021-02 59 mL in 1 BOTTLE, PLASTIC (83107-021-02) Pramosone Legacy Pharma USA Inc. 2025-05-27
83107-0021-04 118 mL in 1 BOTTLE, PLASTIC (83107-021-04) Pramosone Legacy Pharma USA Inc. 2025-05-27
Observed labelers: Legacy Pharma USA Inc. (3) · Sebela Pharmaceuticals Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.